| Home > Authorities > Institutes > Record #144206 |
A360
KKE Mol. Hämatologie/Onkologie Also known as:A360; KKE Molekulare Hämatologie/Onkologie| ID | I:(DE-He78)A360-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors.
Nature biotechnology nn, nn (2026) [10.1038/s41587-026-03152-x]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
(Un-)Known Chances: Emerging Hope for Cancer of Unknown Primary – Highlights from ESMO 2025 and the First International Cancer of Unknown Primary Meeting
Oncology research and treatment nn, nn (2026) [10.1159/000551434]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
68Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of 68Ga-FAPI-46 with 18F-FDG in 13 patients.
European journal of nuclear medicine and molecular imaging nn, nn (2026) [10.1007/s00259-026-07916-0]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy.
Blood cancer discovery 7(3), 479 - 495 (2026) [10.1158/2643-3230.BCD-25-0062]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Schlafen regulates gastrulation in Xenopus laevis early embryonic development and exhibits immune tissue-specific expression in adult frogs.
The international journal of developmental biology nn, nn (2026) [10.1387/ijdb.28997]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Rethinking Multiple Myeloma Treatment: The Biological and Clinical Insights Guiding Immune-Based Combinations.
Blood cancer discovery 7(2), 176-194 (2026) [10.1158/2643-3230.BCD-25-0107]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting metastatic tolerance.
Cancer cell 44(3), 604-623.e9 (2026) [10.1016/j.ccell.2026.01.003]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.
Blood cancer discovery 7(5), 742 - 758 (2026) [10.1158/2643-3230.BCD-25-0259]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
Journal of clinical oncology nn, nn (2026) [10.1200/JCO-25-02974]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.
Leukemia 40(4), 730-738 (2026) [10.1038/s41375-026-02889-3]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |